A Genome-Wide Approach for Restoring Antibiotic Susceptibility to Drug-Resistant Mycobacterium tuberculosis.

恢复耐药结核分枝杆菌抗生素敏感性的全基因组方法。

• 批准号: 472899
• 负责人: Reed Michael B
• 金额: $ 7.29万
• 依托单位: Research Institute of the McGill University Health Centre
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-09-01 至 2023-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=472899&lang=en
• 关键词: Antimicrobial Resistance; Bacterial Genetics; Bioinformatics; Drug Screening; Genomics; Medicinal Chemistry; Molecular Microbiology; Mycobacterium Tuberculosis; Tuberculosis

Despite the availability of antibiotic drug treatment for more than 50 years, almost 2 million people globally still die from tuberculosis (TB) each year. In particular, the spread of multidrug resistant (MDR) forms of Mycobacterium tuberculosis is one of

尽管抗生素药物治疗已有 50 多年的历史，但全球每年仍有近 200 万人死于结核病 (TB)。特别是，耐多药（MDR）形式的结核分枝杆菌的传播是其中之一